A case of probable trimethoprim-sulfamethoxazole induced circulating antineutrophil cytoplasmic antibody-positive small vessel vasculitis.
暂无分享,去创建一个
[1] J. Sweeney,et al. Sulfamethoxazole‐induced thrombocytopenia masquerading as posttransfusion purpura: a case report , 2015, Transfusion.
[2] R. Grau. Drug-Induced Vasculitis: New Insights and a Changing Lineup of Suspects , 2015, Current Rheumatology Reports.
[3] J. Niles,et al. Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis , 2014, Current opinion in rheumatology.
[4] J. Silverberg,et al. Antiphospholipid antibody syndrome secondary to trimethoprim/sulfamethoxazole. , 2012, Journal of drugs in dermatology : JDD.
[5] K. Tsiveriotis,et al. Antineutrophil Cytoplasmic Antibodies Testing in a Large Cohort of Unselected Greek Patients , 2011, Autoimmune diseases.
[6] A. Wiik. Drug-induced vasculitis , 2008, Current opinion in rheumatology.
[7] J. Callen,et al. Tissue eosinophilia as an indicator of drug-induced cutaneous small-vessel vasculitis. , 2006, Archives of dermatology.
[8] P. Merkel,et al. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. , 2000, Arthritis and rheumatism.
[9] R. Falk,et al. Diagnostic predictive value of ANCA serology. , 1998, Kidney international.
[10] D A Bloch,et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Patients and methods. , 2010, Arthritis and rheumatism.
[11] F. Mullick,et al. Drug related vasculitis. Clinicopathologic correlations in 30 patients. , 1979, Human pathology.